Mount Sinai Hospital
Locations
Transplant Summary
Overview
Established in 1990, this program has earned an international reputation for innovation and expertise, by providing specialized care to patients with a wide range of diseases requiring autologous, allogeneic and cord transplants. This is a FACT-accredited facility that received & maintained the Magnet Award for Recognition in nursing.This center has been performing allogeneic transplants since 1990 and has been an NMDP transplant center since March 1994.
Attending physicians
Adult - Jacques Azzi, Aaron Etra, James Ferrara, Uroosa Ibrahim, Luis Isola, Alla Keyzner, John Levine, Adriana Malone, Keren Osman
Pediatric - John LevineTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult onlyOther programs and services
We have immune effector cell therapy and gene therapy programs encompassing commercial and research products for various indications.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 125 patients.The actual 1-year survival of these patients is 71.2%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 63.5% and 78.6%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
410
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow2PBSC49Cord blood0Total51Unrelated donorMarrow2PBSC36Cord blood4Total42Total allogeneicMarrow4PBSC85Cord blood4Total93AutologousMarrowBoth marrow & PBSC 317PBSC—Cord blood—Total317Total combinedMarrowBoth marrow & PBSC 406PBSC—Cord blood4Total410Total pediatric transplants
3
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow0PBSC0Cord blood0Total0Unrelated donorMarrow0PBSC0Cord blood0Total0Total allogeneicMarrow0PBSC0Cord blood0Total0AutologousMarrowBoth marrow & PBSC 3PBSC—Cord blood—Total3Total combinedMarrowBoth marrow & PBSC 3PBSC—Cord blood0Total3All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-441145-643165+9Total51Unrelated 0-18019-44845-642765+7Total42Autologous 0-18319-443345-6416565+119Total320Total 0-18319-445245-6422365+135Total413Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
The Mount Sinai Hospital
1425 Madison Avenue New York, NY 10028 Phone:212-241-6021 Email:rita.jakubowski@mountsinai.org Overview
The goal of our program is to provide resources and support to patients who have undergone cellular therapy procedures, ensure access to timely preventative care, and address long term complications following the procedure. This can include ongoing medical follow up, referral to other medical surgical departments as needed, social and emotional support, and providing education to patients and caregivers. We will also gather and analyze patient outcomes data to identify key issues that impact quality of life with the goal of ensuring adequate resources for all patients.
Staff
Program Director:Luis Isola, MDProgram Coordinator:Rita Jakubowski, DNPMedical Specialties in Program
Hematology, oncology, We have established strong referral network among various medical and surgical sub-specialties within Mount Sinai Hospital..Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic transplant recipients
- Adults: 6 months to 5 years after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital